Millions Spent On Dueling Ads Over House Drug Pricing Votes

By John Wilkerson / January 7, 2020 at 2:18 PM
Groups for and against House Speaker Nancy Pelosi’s drug pricing bill (H.R. 3) are airing competing ads in the new year: Groups backing Pelosi’s bill thanked lawmakers who voted for the bill in December, and those opposed praise lawmakers who voted for a House GOP alternative. However, the intent of the ad campaigns seem to differ. H.R. 3 backers are giving cover to vulnerable Democrats and Republicans who voted for the bill, while opponents praise Republicans, including some in leadership,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.